metoclopramide and prasugrel hydrochloride

metoclopramide has been researched along with prasugrel hydrochloride in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bauersachs, J; Berliner, C; Flierl, U; Napp, LC; Schäfer, A; Sieweke, JT; Tillmanns, J; Zauner, F	1

Reviews

1 review(s) available for metoclopramide and prasugrel hydrochloride

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for metoclopramide and prasugrel hydrochloride

Article	Year
Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction. Thrombosis and haemostasis, 2017, 01-05, Volume: 117, Issue:1 Topics: Administration, Oral; Aged; Analgesics, Opioid; Blood Platelets; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Female; Humans; Male; Metoclopramide; Middle Aged; Morphine; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2017

Article

Year

Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.

Thrombosis and haemostasis, 2017, 01-05, Volume: 117, Issue:1

Topics: Administration, Oral; Aged; Analgesics, Opioid; Blood Platelets; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Female; Humans; Male; Metoclopramide; Middle Aged; Morphine; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome

2017